Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal Ropivacaine for Pain After Gynecologic Laparoscopy
NCT01623635Phase 3Unknown
- Sponsor
- Università di Padova
- Start
- Feb 2012
- Primary completion
- Sep 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ropivacaine in postoperative pain (4 arms), sponsored by Università di Padova. Primary endpoint: Post-operative pain intensity (NRS score) at 6 hours. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01623635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01623635.